Proactive prophylaxis with azithromycin and hydroxychloroquine in hospitalized patients with COVID-19 (ProPAC-COVID): a statistical analysis plan
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1745-6215
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Proactive prophylaxis with azithromycin and hydroxychloroquine in hospitalized patients with COVID-19 (ProPAC-COVID): a statistical analysis plan ; volume:21 ; number:1 ; day:20 ; month:10 ; year:2020 ; pages:1-9 ; date:12.2020
Trials ; 21, Heft 1 (20.10.2020), 1-9, 12.2020
- Creator
-
Sivapalan, Pradeesh
Ulrik, Charlotte Suppli
Lappere, Therese Sophie
Eklöf, Josefin Viktoria
Shaker, Saher Burhan
Bødtger, Uffe Christian Steinholtz
Browatzki, Andrea
Meyer, Christian Niels
Weinreich, Ulla Møller
Laursen, Christian B.
Biering-Sørensen, Tor
Knop, Filip Krag
Lundgren, Jens D.
Jensen, Jens-Ulrik Stæhr
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13063-020-04795-0
- URN
-
urn:nbn:de:101:1-2020120507412936365152
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:36 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sivapalan, Pradeesh
- Ulrik, Charlotte Suppli
- Lappere, Therese Sophie
- Eklöf, Josefin Viktoria
- Shaker, Saher Burhan
- Bødtger, Uffe Christian Steinholtz
- Browatzki, Andrea
- Meyer, Christian Niels
- Weinreich, Ulla Møller
- Laursen, Christian B.
- Biering-Sørensen, Tor
- Knop, Filip Krag
- Lundgren, Jens D.
- Jensen, Jens-Ulrik Stæhr
- SpringerLink (Online service)
Other Objects (12)
Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial
Hydroxychloroquine – An Antimalarial to Fight COVID-19?
Azithromycin – An Antibiotic to Fight COVID-19?
A systematic review and meta-analysis on chloroquine and hydroxychloroquine as monotherapy or combined with azithromycin in COVID-19 treatment
Chloroquine, hydroxychloroquine, and COVID-19, the Libyan prospective
Safety and Effectiveness of Hydroxychloroquine and Azithromycin Combination Therapy for Treatment of Hospitalized Patients with COVID-19: A Propensity-Matched Study
Lysosomotropic agents including azithromycin, chloroquine and hydroxychloroquine activate the integrated stress response
Arrhythmogenic mechanisms of interleukin-6 combination with hydroxychloroquine and azithromycin in inflammatory diseases
Hydroxychloroquine and chloroquine retinal safety concerns during COVID-19 outbreak
Azithromycin added to hydroxychloroquine for patients admitted to intensive care due to coronavirus disease 2019 (COVID-19)—protocol of randomised controlled trial AZIQUINE-ICU
Hydroxychloroquine and dexamethasone in COVID-19: who won and who lost?
Taiwan’s Proactive Prevention of COVID-19 under Constitutionalism
Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial
Hydroxychloroquine – An Antimalarial to Fight COVID-19?
Azithromycin – An Antibiotic to Fight COVID-19?
A systematic review and meta-analysis on chloroquine and hydroxychloroquine as monotherapy or combined with azithromycin in COVID-19 treatment
Chloroquine, hydroxychloroquine, and COVID-19, the Libyan prospective
Safety and Effectiveness of Hydroxychloroquine and Azithromycin Combination Therapy for Treatment of Hospitalized Patients with COVID-19: A Propensity-Matched Study
Lysosomotropic agents including azithromycin, chloroquine and hydroxychloroquine activate the integrated stress response
Arrhythmogenic mechanisms of interleukin-6 combination with hydroxychloroquine and azithromycin in inflammatory diseases
Hydroxychloroquine and chloroquine retinal safety concerns during COVID-19 outbreak
Azithromycin added to hydroxychloroquine for patients admitted to intensive care due to coronavirus disease 2019 (COVID-19)—protocol of randomised controlled trial AZIQUINE-ICU
Hydroxychloroquine and dexamethasone in COVID-19: who won and who lost?
Taiwan’s Proactive Prevention of COVID-19 under Constitutionalism
Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial
Hydroxychloroquine – An Antimalarial to Fight COVID-19?
Azithromycin – An Antibiotic to Fight COVID-19?
A systematic review and meta-analysis on chloroquine and hydroxychloroquine as monotherapy or combined with azithromycin in COVID-19 treatment
Chloroquine, hydroxychloroquine, and COVID-19, the Libyan prospective
Safety and Effectiveness of Hydroxychloroquine and Azithromycin Combination Therapy for Treatment of Hospitalized Patients with COVID-19: A Propensity-Matched Study
Lysosomotropic agents including azithromycin, chloroquine and hydroxychloroquine activate the integrated stress response
Arrhythmogenic mechanisms of interleukin-6 combination with hydroxychloroquine and azithromycin in inflammatory diseases
Hydroxychloroquine and chloroquine retinal safety concerns during COVID-19 outbreak
Azithromycin added to hydroxychloroquine for patients admitted to intensive care due to coronavirus disease 2019 (COVID-19)—protocol of randomised controlled trial AZIQUINE-ICU
Hydroxychloroquine and dexamethasone in COVID-19: who won and who lost?